1. Home
  2. ADPT vs PL Comparison

ADPT vs PL Comparison

Compare ADPT & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$15.41

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$18.40

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
PL
Founded
2009
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ADPT
PL
Price
$15.41
$18.40
Analyst Decision
Strong Buy
Buy
Analyst Count
10
15
Target Price
$16.60
$13.44
AVG Volume (30 Days)
3.0M
11.0M
Earning Date
11-05-2025
12-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$252,754,000.00
$282,459,000.00
Revenue This Year
$50.81
$19.76
Revenue Next Year
$1.17
$21.72
P/E Ratio
N/A
N/A
Revenue Growth
42.57
16.89
52 Week Low
$5.81
$2.79
52 Week High
$20.76
$19.09

Technical Indicators

Market Signals
Indicator
ADPT
PL
Relative Strength Index (RSI) 44.33 83.09
Support Level $14.58 $12.56
Resistance Level $16.26 $13.23
Average True Range (ATR) 1.13 0.80
MACD -0.36 0.68
Stochastic Oscillator 13.75 91.52

Price Performance

Historical Comparison
ADPT
PL

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

Share on Social Networks: